

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative thymic T cell selection (GO:0045060) | 9.33945768 |
| 2 | regulation of isotype switching to IgG isotypes (GO:0048302) | 8.94740801 |
| 3 | negative regulation of cell killing (GO:0031342) | 8.19939473 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 8.19939473 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.62788413 |
| 6 | thymic T cell selection (GO:0045061) | 7.61065022 |
| 7 | T cell migration (GO:0072678) | 7.57852570 |
| 8 | interferon-gamma production (GO:0032609) | 7.37865130 |
| 9 | activated T cell proliferation (GO:0050798) | 7.18345268 |
| 10 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 7.10565564 |
| 11 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 7.10565564 |
| 12 | regulation of response to tumor cell (GO:0002834) | 7.03383431 |
| 13 | positive regulation of response to tumor cell (GO:0002836) | 7.03383431 |
| 14 | positive regulation of immune response to tumor cell (GO:0002839) | 7.03383431 |
| 15 | regulation of immune response to tumor cell (GO:0002837) | 7.03383431 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.92745756 |
| 17 | regulation of natural killer cell mediated immunity (GO:0002715) | 6.66809539 |
| 18 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 6.66809539 |
| 19 | T cell selection (GO:0045058) | 6.56130237 |
| 20 | sequestering of actin monomers (GO:0042989) | 6.40937586 |
| 21 | positive T cell selection (GO:0043368) | 6.39168308 |
| 22 | positive thymic T cell selection (GO:0045059) | 6.27047269 |
| 23 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.95844041 |
| 24 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.95289994 |
| 25 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.95289994 |
| 26 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.91910384 |
| 27 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.84751368 |
| 28 | cellular response to interleukin-15 (GO:0071350) | 5.72131002 |
| 29 | T cell costimulation (GO:0031295) | 5.57205339 |
| 30 | T cell receptor signaling pathway (GO:0050852) | 5.54443481 |
| 31 | cytidine metabolic process (GO:0046087) | 5.52847001 |
| 32 | cytidine catabolic process (GO:0006216) | 5.52847001 |
| 33 | cytidine deamination (GO:0009972) | 5.52847001 |
| 34 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.51902046 |
| 35 | positive regulation of isotype switching (GO:0045830) | 5.45440017 |
| 36 | lymphocyte costimulation (GO:0031294) | 5.45163524 |
| 37 | response to interleukin-15 (GO:0070672) | 5.41040631 |
| 38 | actin nucleation (GO:0045010) | 5.38822208 |
| 39 | cytolysis (GO:0019835) | 5.33402551 |
| 40 | regulation of gamma-delta T cell activation (GO:0046643) | 5.24400292 |
| 41 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 5.23927780 |
| 42 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.09266824 |
| 43 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.00519053 |
| 44 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.95870505 |
| 45 | leukocyte aggregation (GO:0070486) | 4.93839955 |
| 46 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 4.89907687 |
| 47 | positive regulation of B cell mediated immunity (GO:0002714) | 4.89907687 |
| 48 | heterotypic cell-cell adhesion (GO:0034113) | 4.85091833 |
| 49 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.82425142 |
| 50 | DNA deamination (GO:0045006) | 4.80742343 |
| 51 | positive regulation of DNA recombination (GO:0045911) | 4.79731902 |
| 52 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.71408809 |
| 53 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.65228928 |
| 54 | lymphocyte migration (GO:0072676) | 4.54108028 |
| 55 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.46933726 |
| 56 | positive regulation of B cell differentiation (GO:0045579) | 4.46139726 |
| 57 | regulation of isotype switching (GO:0045191) | 4.45986915 |
| 58 | negative regulation of T cell mediated immunity (GO:0002710) | 4.35130799 |
| 59 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.33565771 |
| 60 | negative regulation of T cell apoptotic process (GO:0070233) | 4.32895361 |
| 61 | negative regulation of stress fiber assembly (GO:0051497) | 4.31453310 |
| 62 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.25429414 |
| 63 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 4.23751358 |
| 64 | regulation of immunoglobulin mediated immune response (GO:0002889) | 4.20997957 |
| 65 | positive regulation of cell killing (GO:0031343) | 4.19021590 |
| 66 | regulation of T cell tolerance induction (GO:0002664) | 4.18875803 |
| 67 | cellular defense response (GO:0006968) | 4.17340915 |
| 68 | regulation of defense response to virus by virus (GO:0050690) | 4.14406974 |
| 69 | leukocyte cell-cell adhesion (GO:0007159) | 4.12782318 |
| 70 | regulation of regulatory T cell differentiation (GO:0045589) | 4.11158043 |
| 71 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 4.10756884 |
| 72 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.09947962 |
| 73 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.08926947 |
| 74 | regulation of cell killing (GO:0031341) | 4.08691128 |
| 75 | mast cell activation (GO:0045576) | 4.08479087 |
| 76 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.08432769 |
| 77 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.05306594 |
| 78 | regulation of B cell mediated immunity (GO:0002712) | 4.04401962 |
| 79 | positive regulation of calcium-mediated signaling (GO:0050850) | 4.04360523 |
| 80 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.00242880 |
| 81 | regulation of activation of Janus kinase activity (GO:0010533) | 3.93398151 |
| 82 | respiratory burst (GO:0045730) | 3.80860117 |
| 83 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.78614951 |
| 84 | positive regulation of interleukin-2 production (GO:0032743) | 3.74515236 |
| 85 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.71409526 |
| 86 | positive regulation of lamellipodium assembly (GO:0010592) | 3.60785015 |
| 87 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.52733127 |
| 88 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.52585477 |
| 89 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.50594728 |
| 90 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.46854473 |
| 91 | leukocyte tethering or rolling (GO:0050901) | 3.46668053 |
| 92 | T cell differentiation (GO:0030217) | 3.46121567 |
| 93 | positive regulation of interleukin-4 production (GO:0032753) | 3.41698954 |
| 94 | T cell activation (GO:0042110) | 3.40543689 |
| 95 | negative regulation of viral genome replication (GO:0045071) | 3.40234300 |
| 96 | natural killer cell activation (GO:0030101) | 3.36131756 |
| 97 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.35521874 |
| 98 | T cell proliferation (GO:0042098) | 3.34753948 |
| 99 | positive regulation of immunoglobulin production (GO:0002639) | 3.32682920 |
| 100 | negative regulation of phagocytosis (GO:0050765) | 3.32603864 |
| 101 | type I interferon signaling pathway (GO:0060337) | 3.28748705 |
| 102 | cellular response to type I interferon (GO:0071357) | 3.28748705 |
| 103 | negative regulation of type 2 immune response (GO:0002829) | 3.27934868 |
| 104 | positive regulation of T cell chemotaxis (GO:0010820) | 3.26400369 |
| 105 | regulation of T cell chemotaxis (GO:0010819) | 3.26400369 |
| 106 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.25153813 |
| 107 | response to type I interferon (GO:0034340) | 3.24815013 |
| 108 | positive regulation of viral genome replication (GO:0045070) | 3.23943884 |
| 109 | positive regulation of tolerance induction (GO:0002645) | 3.23681519 |
| 110 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.21559856 |
| 111 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.21134750 |
| 112 | negative regulation of actin filament bundle assembly (GO:0032232) | 3.21132293 |
| 113 | lymphocyte chemotaxis (GO:0048247) | 3.19332192 |
| 114 | immunoglobulin mediated immune response (GO:0016064) | 3.17629457 |
| 115 | NIK/NF-kappaB signaling (GO:0038061) | 3.17436444 |
| 116 | T cell mediated immunity (GO:0002456) | 3.14944337 |
| 117 | regulation of T cell apoptotic process (GO:0070232) | 3.14297681 |
| 118 | positive regulation of T cell mediated immunity (GO:0002711) | 3.07563582 |
| 119 | regulation of response to interferon-gamma (GO:0060330) | 3.07005732 |
| 120 | response to interferon-beta (GO:0035456) | 3.06277013 |
| 121 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.05953702 |
| 122 | mast cell degranulation (GO:0043303) | 3.05950438 |
| 123 | mast cell activation involved in immune response (GO:0002279) | 3.05950438 |
| 124 | B cell receptor signaling pathway (GO:0050853) | 3.05671702 |
| 125 | dendritic cell chemotaxis (GO:0002407) | 3.01748898 |
| 126 | positive regulation of T cell activation (GO:0050870) | 2.99982413 |
| 127 | regulation of B cell differentiation (GO:0045577) | 2.99939770 |
| 128 | negative regulation of oxidoreductase activity (GO:0051354) | 2.99552019 |
| 129 | positive regulation of leukocyte mediated immunity (GO:0002705) | 2.96871412 |
| 130 | regulation of immunoglobulin production (GO:0002637) | 2.89909059 |
| 131 | signal complex assembly (GO:0007172) | 2.87211649 |
| 132 | positive regulation of T cell proliferation (GO:0042102) | 2.86440987 |
| 133 | positive regulation of lamellipodium organization (GO:1902745) | 2.84245680 |
| 134 | regulation of tolerance induction (GO:0002643) | 2.83789030 |
| 135 | alpha-beta T cell activation (GO:0046631) | 2.83430805 |
| 136 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.81751197 |
| 137 | negative T cell selection (GO:0043383) | 10.0186624 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.35519912 |
| 2 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.66788935 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.03711419 |
| 4 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 4.23732189 |
| 5 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.12893573 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.98181505 |
| 7 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.85171577 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.75538571 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.65271792 |
| 10 | MYB_26560356_Chip-Seq_TH2_Human | 3.60719566 |
| 11 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.59014049 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.51395730 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.21996159 |
| 14 | MAF_26560356_Chip-Seq_TH1_Human | 2.98469781 |
| 15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.81908674 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.79502307 |
| 17 | * MYB_26560356_Chip-Seq_TH1_Human | 2.70727533 |
| 18 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.70579470 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.63661785 |
| 20 | MYC_22102868_ChIP-Seq_BL_Human | 2.51760244 |
| 21 | MAF_26560356_Chip-Seq_TH2_Human | 2.27341528 |
| 22 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.21076003 |
| 23 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.20598407 |
| 24 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.19150363 |
| 25 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.13350180 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.12166527 |
| 27 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.04037751 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.00223348 |
| 29 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.96693565 |
| 30 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.95451200 |
| 31 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.86672504 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.85163522 |
| 33 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.81968373 |
| 34 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.77050030 |
| 35 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.76144241 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.74756535 |
| 37 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.73658362 |
| 38 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.72467780 |
| 39 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.57162785 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.56445663 |
| 41 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.53146422 |
| 42 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.50751320 |
| 43 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.47871374 |
| 44 | GATA3_26560356_Chip-Seq_TH2_Human | 1.47532235 |
| 45 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.47459966 |
| 46 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46400788 |
| 47 | VDR_22108803_ChIP-Seq_LS180_Human | 1.45101231 |
| 48 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.44509334 |
| 49 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43083019 |
| 50 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.42856437 |
| 51 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.42552968 |
| 52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.39398926 |
| 53 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.38236862 |
| 54 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.35309611 |
| 55 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.34755433 |
| 56 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34516999 |
| 57 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.33760139 |
| 58 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32945077 |
| 59 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.29607043 |
| 60 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.26231800 |
| 61 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.26212137 |
| 62 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.25885048 |
| 63 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.21354033 |
| 64 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.19944070 |
| 65 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17837757 |
| 66 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.17313039 |
| 67 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16499773 |
| 68 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.16222504 |
| 69 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14247473 |
| 70 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.12891206 |
| 71 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.11087984 |
| 72 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.10187082 |
| 73 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09883925 |
| 74 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09624260 |
| 75 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09560569 |
| 76 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08346052 |
| 77 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.07973259 |
| 78 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.07000969 |
| 79 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03377244 |
| 80 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.01903797 |
| 81 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01830427 |
| 82 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.01681125 |
| 83 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.01624274 |
| 84 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.00011097 |
| 85 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.99943061 |
| 86 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.98389212 |
| 87 | P300_27268052_Chip-Seq_Bcells_Human | 0.98222044 |
| 88 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.97627746 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.97271542 |
| 90 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.95035939 |
| 91 | SA1_27219007_Chip-Seq_Bcells_Human | 0.92678677 |
| 92 | * FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.91562594 |
| 93 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91506519 |
| 94 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.91214130 |
| 95 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.90499417 |
| 96 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89735127 |
| 97 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.89224803 |
| 98 | NCOR_22424771_ChIP-Seq_293T_Human | 0.89211200 |
| 99 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.88760791 |
| 100 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.88423214 |
| 101 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87986733 |
| 102 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.85931519 |
| 103 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85350356 |
| 104 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.83945022 |
| 105 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83503952 |
| 106 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.82802584 |
| 107 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.82372977 |
| 108 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.81892047 |
| 109 | AR_20517297_ChIP-Seq_VCAP_Human | 0.81108698 |
| 110 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80469356 |
| 111 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.78839179 |
| 112 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.78633386 |
| 113 | * TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78513352 |
| 114 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.77724319 |
| 115 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.76846847 |
| 116 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.76498185 |
| 117 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.76202347 |
| 118 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.75858118 |
| 119 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.75356362 |
| 120 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.74897976 |
| 121 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.74451940 |
| 122 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.74374795 |
| 123 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.74257289 |
| 124 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.73636547 |
| 125 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.73331684 |
| 126 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.73184322 |
| 127 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.70930779 |
| 128 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.70837696 |
| 129 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.70447200 |
| 130 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.69305137 |
| 131 | GATA3_26560356_Chip-Seq_TH1_Human | 0.69262599 |
| 132 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.68780482 |
| 133 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.68755693 |
| 134 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.68662741 |
| 135 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.67208534 |
| 136 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.66822347 |
| 137 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.66451586 |
| 138 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.66147113 |
| 139 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.66079516 |
| 140 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.65604298 |
| 141 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.64355309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 6.53103240 |
| 2 | MP0003763_abnormal_thymus_physiology | 6.43562481 |
| 3 | MP0006082_CNS_inflammation | 4.05097117 |
| 4 | MP0009333_abnormal_splenocyte_physiolog | 3.66484432 |
| 5 | MP0000858_altered_metastatic_potential | 3.32551773 |
| 6 | MP0002420_abnormal_adaptive_immunity | 3.28598036 |
| 7 | MP0001819_abnormal_immune_cell | 3.22212949 |
| 8 | MP0001800_abnormal_humoral_immune | 3.16825274 |
| 9 | MP0000685_abnormal_immune_system | 3.12119317 |
| 10 | MP0002398_abnormal_bone_marrow | 3.11290407 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.98277036 |
| 12 | MP0005025_abnormal_response_to | 2.89340886 |
| 13 | MP0002723_abnormal_immune_serum | 2.87031778 |
| 14 | MP0005387_immune_system_phenotype | 2.85920365 |
| 15 | MP0001790_abnormal_immune_system | 2.85920365 |
| 16 | MP0003448_altered_tumor_morphology | 2.83160491 |
| 17 | MP0009785_altered_susceptibility_to | 2.73912839 |
| 18 | MP0000703_abnormal_thymus_morphology | 2.68878687 |
| 19 | MP0000716_abnormal_immune_system | 2.65114515 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.54140639 |
| 21 | MP0002405_respiratory_system_inflammati | 2.51432616 |
| 22 | MP0002166_altered_tumor_susceptibility | 2.50324254 |
| 23 | MP0002722_abnormal_immune_system | 2.39691945 |
| 24 | MP0001835_abnormal_antigen_presentation | 2.29489418 |
| 25 | MP0000689_abnormal_spleen_morphology | 2.25413792 |
| 26 | MP0002006_tumorigenesis | 2.23024957 |
| 27 | MP0002429_abnormal_blood_cell | 2.15227460 |
| 28 | MP0004947_skin_inflammation | 1.95004128 |
| 29 | MP0003724_increased_susceptibility_to | 1.93506611 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.92167457 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 1.87996794 |
| 32 | MP0003436_decreased_susceptibility_to | 1.86639982 |
| 33 | MP0002933_joint_inflammation | 1.84738937 |
| 34 | MP0002419_abnormal_innate_immunity | 1.83556567 |
| 35 | MP0003646_muscle_fatigue | 1.75802774 |
| 36 | MP0003045_fibrosis | 1.74866414 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.69605140 |
| 38 | MP0002132_abnormal_respiratory_system | 1.67190623 |
| 39 | MP0005645_abnormal_hypothalamus_physiol | 1.66959810 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.60522191 |
| 41 | MP0003866_abnormal_defecation | 1.57600762 |
| 42 | MP0002277_abnormal_respiratory_mucosa | 1.48164542 |
| 43 | MP0001986_abnormal_taste_sensitivity | 1.38283624 |
| 44 | MP0002019_abnormal_tumor_incidence | 1.33489236 |
| 45 | MP0002396_abnormal_hematopoietic_system | 1.32086762 |
| 46 | MP0001873_stomach_inflammation | 1.31155899 |
| 47 | MP0008469_abnormal_protein_level | 1.20819482 |
| 48 | MP0003878_abnormal_ear_physiology | 1.20205703 |
| 49 | MP0005377_hearing/vestibular/ear_phenot | 1.20205703 |
| 50 | MP0002822_catalepsy | 1.15528706 |
| 51 | MP0008872_abnormal_physiological_respon | 1.12345285 |
| 52 | MP0003806_abnormal_nucleotide_metabolis | 1.11631284 |
| 53 | MP0008057_abnormal_DNA_replication | 1.10934467 |
| 54 | MP0002009_preneoplasia | 1.06381944 |
| 55 | MP0001853_heart_inflammation | 1.03261261 |
| 56 | MP0002102_abnormal_ear_morphology | 1.00866757 |
| 57 | MP0009764_decreased_sensitivity_to | 0.98467846 |
| 58 | MP0003011_delayed_dark_adaptation | 0.98089403 |
| 59 | MP0001851_eye_inflammation | 0.97886973 |
| 60 | MP0004957_abnormal_blastocyst_morpholog | 0.97034228 |
| 61 | MP0009763_increased_sensitivity_to | 0.96623917 |
| 62 | MP0003787_abnormal_imprinting | 0.96289866 |
| 63 | MP0002998_abnormal_bone_remodeling | 0.96100521 |
| 64 | MP0006054_spinal_hemorrhage | 0.95686561 |
| 65 | MP0001533_abnormal_skeleton_physiology | 0.93517919 |
| 66 | MP0008961_abnormal_basal_metabolism | 0.91400868 |
| 67 | MP0005166_decreased_susceptibility_to | 0.89460049 |
| 68 | MP0008877_abnormal_DNA_methylation | 0.87568888 |
| 69 | MP0001542_abnormal_bone_strength | 0.86552778 |
| 70 | MP0005451_abnormal_body_composition | 0.86412905 |
| 71 | MP0001919_abnormal_reproductive_system | 0.83174302 |
| 72 | MP0003950_abnormal_plasma_membrane | 0.82289701 |
| 73 | MP0000604_amyloidosis | 0.80816126 |
| 74 | MP0005410_abnormal_fertilization | 0.79474389 |
| 75 | MP0010352_gastrointestinal_tract_polyps | 0.78126562 |
| 76 | MP0004808_abnormal_hematopoietic_stem | 0.77593674 |
| 77 | MP0003075_altered_response_to | 0.75772493 |
| 78 | MP0001765_abnormal_ion_homeostasis | 0.74316657 |
| 79 | MP0001529_abnormal_vocalization | 0.74096492 |
| 80 | MP0000920_abnormal_myelination | 0.73753316 |
| 81 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.70098117 |
| 82 | MP0004883_abnormal_blood_vessel | 0.69481429 |
| 83 | MP0003300_gastrointestinal_ulcer | 0.69274161 |
| 84 | MP0005623_abnormal_meninges_morphology | 0.68507826 |
| 85 | MP0002693_abnormal_pancreas_physiology | 0.66394543 |
| 86 | MP0003690_abnormal_glial_cell | 0.66093126 |
| 87 | MP0000490_abnormal_crypts_of | 0.65954712 |
| 88 | MP0002138_abnormal_hepatobiliary_system | 0.65553824 |
| 89 | MP0003279_aneurysm | 0.64739309 |
| 90 | MP0005058_abnormal_lysosome_morphology | 0.63890741 |
| 91 | MP0002136_abnormal_kidney_physiology | 0.63707308 |
| 92 | MP0003137_abnormal_impulse_conducting | 0.63622082 |
| 93 | MP0008873_increased_physiological_sensi | 0.61632104 |
| 94 | MP0003172_abnormal_lysosome_physiology | 0.61195064 |
| 95 | MP0001968_abnormal_touch/_nociception | 0.60501769 |
| 96 | MP0002163_abnormal_gland_morphology | 0.60299660 |
| 97 | MP0004510_myositis | 0.59711019 |
| 98 | MP0003656_abnormal_erythrocyte_physiolo | 0.58876049 |
| 99 | MP0009643_abnormal_urine_homeostasis | 0.57864429 |
| 100 | MP0005390_skeleton_phenotype | 0.56354334 |
| 101 | MP0008875_abnormal_xenobiotic_pharmacok | 0.56036866 |
| 102 | MP0003183_abnormal_peptide_metabolism | 0.55198706 |
| 103 | MP0001243_abnormal_dermal_layer | 0.54204836 |
| 104 | MP0005551_abnormal_eye_electrophysiolog | 0.54116481 |
| 105 | MP0001191_abnormal_skin_condition | 0.53952898 |
| 106 | MP0004130_abnormal_muscle_cell | 0.53641688 |
| 107 | MP0005636_abnormal_mineral_homeostasis | 0.53285407 |
| 108 | MP0004145_abnormal_muscle_electrophysio | 0.52615584 |
| 109 | MP0003786_premature_aging | 0.52149260 |
| 110 | MP0001501_abnormal_sleep_pattern | 0.50702461 |
| 111 | MP0009642_abnormal_blood_homeostasis | 0.50059999 |
| 112 | MP0008995_early_reproductive_senescence | 0.49839378 |
| 113 | MP0001663_abnormal_digestive_system | 0.49369672 |
| 114 | MP0003693_abnormal_embryo_hatching | 0.49038916 |
| 115 | MP0004147_increased_porphyrin_level | 0.48673324 |
| 116 | MP0002083_premature_death | 0.48606034 |
| 117 | MP0003252_abnormal_bile_duct | 0.47942733 |
| 118 | MP0005164_abnormal_response_to | 0.47597549 |
| 119 | MP0003077_abnormal_cell_cycle | 0.46833648 |
| 120 | MP0003880_abnormal_central_pattern | 0.46661877 |
| 121 | MP0005379_endocrine/exocrine_gland_phen | 0.45402619 |
| 122 | MP0010234_abnormal_vibrissa_follicle | 0.44506985 |
| 123 | MP0003795_abnormal_bone_structure | 0.44247688 |
| 124 | MP0000609_abnormal_liver_physiology | 0.43537815 |
| 125 | MP0008770_decreased_survivor_rate | 0.42901081 |
| 126 | MP0004859_abnormal_synaptic_plasticity | 0.42741000 |
| 127 | MP0005023_abnormal_wound_healing | 0.41940396 |
| 128 | MP0003566_abnormal_cell_adhesion | 0.41245405 |
| 129 | MP0004381_abnormal_hair_follicle | 0.40039477 |
| 130 | MP0002127_abnormal_cardiovascular_syste | 0.39641028 |
| 131 | MP0003943_abnormal_hepatobiliary_system | 0.39530746 |
| 132 | MP0003111_abnormal_nucleus_morphology | 0.39118963 |
| 133 | MP0000613_abnormal_salivary_gland | 0.37202395 |
| 134 | MP0005360_urolithiasis | 0.34938906 |
| 135 | MP0010094_abnormal_chromosome_stability | 0.33758257 |
| 136 | MP0000477_abnormal_intestine_morphology | 0.32847991 |
| 137 | MP0000465_gastrointestinal_hemorrhage | 0.31367004 |
| 138 | MP0009745_abnormal_behavioral_response | 0.31331745 |
| 139 | MP0005310_abnormal_salivary_gland | 0.31045849 |
| 140 | MP0008874_decreased_physiological_sensi | 0.30051151 |
| 141 | MP0001905_abnormal_dopamine_level | 0.29552074 |
| 142 | MP0005075_abnormal_melanosome_morpholog | 0.29347663 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 9.11091722 |
| 2 | Abnormality of T cell number (HP:0011839) | 8.65583131 |
| 3 | Aplastic anemia (HP:0001915) | 7.12068434 |
| 4 | Nasal polyposis (HP:0100582) | 5.49129554 |
| 5 | Combined immunodeficiency (HP:0005387) | 5.30531199 |
| 6 | Abnormality of T cells (HP:0002843) | 5.22105640 |
| 7 | Severe combined immunodeficiency (HP:0004430) | 4.82160192 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.81181221 |
| 9 | Hypoproteinemia (HP:0003075) | 4.48918676 |
| 10 | Gastrointestinal infarctions (HP:0005244) | 4.47318518 |
| 11 | Abnormality of the nasal mucosa (HP:0000433) | 4.38104831 |
| 12 | Abnormality of oral frenula (HP:0000190) | 4.35988337 |
| 13 | Joint swelling (HP:0001386) | 4.24399902 |
| 14 | Chronic otitis media (HP:0000389) | 4.10051076 |
| 15 | Encephalitis (HP:0002383) | 4.07192952 |
| 16 | Increased IgM level (HP:0003496) | 4.05636893 |
| 17 | Recurrent bronchitis (HP:0002837) | 4.02379937 |
| 18 | IgG deficiency (HP:0004315) | 3.87023215 |
| 19 | IgM deficiency (HP:0002850) | 3.76333187 |
| 20 | Pustule (HP:0200039) | 3.76261059 |
| 21 | Myositis (HP:0100614) | 3.69161325 |
| 22 | Abnormality of binocular vision (HP:0011514) | 3.45565933 |
| 23 | Diplopia (HP:0000651) | 3.45565933 |
| 24 | Recurrent abscess formation (HP:0002722) | 3.45382806 |
| 25 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.42110344 |
| 26 | Recurrent viral infections (HP:0004429) | 3.38335162 |
| 27 | Abnormality of eosinophils (HP:0001879) | 3.36242985 |
| 28 | Renal cortical cysts (HP:0000803) | 3.31266776 |
| 29 | Abnormality of the prostate (HP:0008775) | 3.30815606 |
| 30 | Meningitis (HP:0001287) | 3.26308633 |
| 31 | Congenital stationary night blindness (HP:0007642) | 3.23726024 |
| 32 | Eczematoid dermatitis (HP:0000976) | 3.22234784 |
| 33 | Leukocytosis (HP:0001974) | 3.17550952 |
| 34 | Abnormality of B cell number (HP:0010975) | 3.16048149 |
| 35 | Trigonocephaly (HP:0000243) | 3.15963452 |
| 36 | Lymphopenia (HP:0001888) | 3.12993242 |
| 37 | Keratoconjunctivitis sicca (HP:0001097) | 3.07641582 |
| 38 | Chronic obstructive pulmonary disease (HP:0006510) | 3.07292732 |
| 39 | Obstructive lung disease (HP:0006536) | 3.07292732 |
| 40 | 3-Methylglutaconic aciduria (HP:0003535) | 3.06132990 |
| 41 | Pancytopenia (HP:0001876) | 3.04733333 |
| 42 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.95592178 |
| 43 | Autoimmune hemolytic anemia (HP:0001890) | 2.94515552 |
| 44 | Ureteral stenosis (HP:0000071) | 2.91800266 |
| 45 | Recurrent fungal infections (HP:0002841) | 2.87500426 |
| 46 | Autoimmune thrombocytopenia (HP:0001973) | 2.86138773 |
| 47 | Spontaneous hematomas (HP:0007420) | 2.84700716 |
| 48 | Hemoptysis (HP:0002105) | 2.82078246 |
| 49 | Amaurosis fugax (HP:0100576) | 2.76154181 |
| 50 | Pulmonary embolism (HP:0002204) | 2.76011512 |
| 51 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.74429542 |
| 52 | Eosinophilia (HP:0001880) | 2.74361734 |
| 53 | Keratoconjunctivitis (HP:0001096) | 2.72261922 |
| 54 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.69875975 |
| 55 | Panhypogammaglobulinemia (HP:0003139) | 2.66768932 |
| 56 | Amyotrophic lateral sclerosis (HP:0007354) | 2.65979487 |
| 57 | Ureteral obstruction (HP:0006000) | 2.65747012 |
| 58 | Stomach cancer (HP:0012126) | 2.61796498 |
| 59 | Increased intramyocellular lipid droplets (HP:0012240) | 2.59982747 |
| 60 | Basal cell carcinoma (HP:0002671) | 2.56157255 |
| 61 | Mediastinal lymphadenopathy (HP:0100721) | 2.55735839 |
| 62 | Recurrent otitis media (HP:0000403) | 2.50644951 |
| 63 | Stomatitis (HP:0010280) | 2.49182063 |
| 64 | Nonimmune hydrops fetalis (HP:0001790) | 2.48999671 |
| 65 | Epistaxis (HP:0000421) | 2.46844541 |
| 66 | Thyroiditis (HP:0100646) | 2.45310443 |
| 67 | Pulmonary infiltrates (HP:0002113) | 2.44731855 |
| 68 | Vasculitis (HP:0002633) | 2.43339866 |
| 69 | Hypergammaglobulinemia (HP:0010702) | 2.42295522 |
| 70 | Optic neuritis (HP:0100653) | 2.41518294 |
| 71 | Retrobulbar optic neuritis (HP:0100654) | 2.41518294 |
| 72 | Recurrent skin infections (HP:0001581) | 2.40441232 |
| 73 | Recurrent sinusitis (HP:0011108) | 2.39236620 |
| 74 | Abnormal foot bone ossification (HP:0010675) | 2.37869657 |
| 75 | Abnormal platelet volume (HP:0011876) | 2.32613092 |
| 76 | Dislocated radial head (HP:0003083) | 2.29580182 |
| 77 | Gangrene (HP:0100758) | 2.28081743 |
| 78 | Arterial thrombosis (HP:0004420) | 2.27758712 |
| 79 | Increased muscle lipid content (HP:0009058) | 2.27352828 |
| 80 | Lymphoma (HP:0002665) | 2.27318357 |
| 81 | Gastrointestinal inflammation (HP:0004386) | 2.27279913 |
| 82 | Pigmentary retinal degeneration (HP:0001146) | 2.26899445 |
| 83 | Verrucae (HP:0200043) | 2.26126941 |
| 84 | Papilloma (HP:0012740) | 2.26126941 |
| 85 | Recurrent cutaneous fungal infections (HP:0011370) | 2.25037194 |
| 86 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.25037194 |
| 87 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.23395319 |
| 88 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.23213629 |
| 89 | Oral leukoplakia (HP:0002745) | 2.21276517 |
| 90 | Aortic dissection (HP:0002647) | 2.21138745 |
| 91 | Abnormality of the alveolar ridges (HP:0006477) | 2.20644002 |
| 92 | Granulocytopenia (HP:0001913) | 2.19811899 |
| 93 | Abnormality of the fingertips (HP:0001211) | 2.19192144 |
| 94 | Bronchitis (HP:0012387) | 2.18702828 |
| 95 | B lymphocytopenia (HP:0010976) | 2.16978583 |
| 96 | Chronic sinusitis (HP:0011109) | 2.15946367 |
| 97 | Chest pain (HP:0100749) | 2.15574545 |
| 98 | Prostate neoplasm (HP:0100787) | 2.14699952 |
| 99 | Papilledema (HP:0001085) | 2.13270342 |
| 100 | Increased IgE level (HP:0003212) | 2.12732965 |
| 101 | Abnormality of the radial head (HP:0003995) | 2.12646830 |
| 102 | Anorexia (HP:0002039) | 2.11523242 |
| 103 | Mitochondrial inheritance (HP:0001427) | 2.10130674 |
| 104 | Acrocyanosis (HP:0001063) | 2.08898465 |
| 105 | Attenuation of retinal blood vessels (HP:0007843) | 2.06625565 |
| 106 | Recurrent bacterial skin infections (HP:0005406) | 2.05279266 |
| 107 | Abnormality of macrophages (HP:0004311) | 2.01819926 |
| 108 | Orchitis (HP:0100796) | 2.00952631 |
| 109 | Abnormal albumin level (HP:0012116) | 1.99621954 |
| 110 | Hypoalbuminemia (HP:0003073) | 1.99621954 |
| 111 | Premature graying of hair (HP:0002216) | 1.98872512 |
| 112 | Radial bowing (HP:0002986) | 1.98638739 |
| 113 | Vertebral arch anomaly (HP:0008438) | 1.97945366 |
| 114 | Increased hepatocellular lipid droplets (HP:0006565) | 1.97516843 |
| 115 | Cellular immunodeficiency (HP:0005374) | 1.96232160 |
| 116 | Inflammation of the large intestine (HP:0002037) | 1.95768495 |
| 117 | Severe visual impairment (HP:0001141) | 1.95280982 |
| 118 | Cerebral palsy (HP:0100021) | 1.94069794 |
| 119 | Hemiplegia (HP:0002301) | 1.92828456 |
| 120 | Abnormality of T cell physiology (HP:0011840) | 1.91791417 |
| 121 | Prolonged bleeding time (HP:0003010) | 1.91303682 |
| 122 | Chronic diarrhea (HP:0002028) | 1.91068520 |
| 123 | Increased mean platelet volume (HP:0011877) | 1.90605769 |
| 124 | Periorbital edema (HP:0100539) | 1.87849912 |
| 125 | Purpura (HP:0000979) | 1.87505828 |
| 126 | Acute hepatic failure (HP:0006554) | 1.84765746 |
| 127 | Growth hormone excess (HP:0000845) | 1.84668577 |
| 128 | Hypochromic anemia (HP:0001931) | 1.83004705 |
| 129 | Microcytic anemia (HP:0001935) | 1.80254492 |
| 130 | Bronchiectasis (HP:0002110) | 1.79153727 |
| 131 | Hypoplasia of the thymus (HP:0000778) | 1.78444804 |
| 132 | Acute necrotizing encephalopathy (HP:0006965) | 1.77362503 |
| 133 | Petechiae (HP:0000967) | 1.74024509 |
| 134 | Urticaria (HP:0001025) | 1.73840414 |
| 135 | Renal Fanconi syndrome (HP:0001994) | 1.73802332 |
| 136 | Lipid accumulation in hepatocytes (HP:0006561) | 1.73398023 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.44832360 |
| 2 | MAP4K1 | 6.19252001 |
| 3 | ITK | 5.36219069 |
| 4 | SCYL2 | 3.20064674 |
| 5 | MST4 | 3.16184176 |
| 6 | TESK2 | 2.98439909 |
| 7 | ZAP70 | 2.96745273 |
| 8 | GRK6 | 2.70872099 |
| 9 | STK10 | 2.69048277 |
| 10 | JAK3 | 2.53481138 |
| 11 | CSK | 2.20486171 |
| 12 | MUSK | 2.15858015 |
| 13 | LCK | 2.10891007 |
| 14 | CLK1 | 2.09310206 |
| 15 | MAP3K12 | 1.88477360 |
| 16 | TNK2 | 1.81835575 |
| 17 | TYK2 | 1.75582658 |
| 18 | FES | 1.62859472 |
| 19 | JAK1 | 1.58309330 |
| 20 | MAP3K11 | 1.54024074 |
| 21 | PRKCQ | 1.49991322 |
| 22 | CAMKK1 | 1.45913713 |
| 23 | GRK7 | 1.44981220 |
| 24 | LRRK2 | 1.44601349 |
| 25 | SYK | 1.43084508 |
| 26 | TEC | 1.39898470 |
| 27 | CAMKK2 | 1.36535032 |
| 28 | KDR | 1.35864865 |
| 29 | BLK | 1.35529622 |
| 30 | FGFR4 | 1.32461437 |
| 31 | PRKCH | 1.32399498 |
| 32 | STK16 | 1.29477744 |
| 33 | VRK2 | 1.24775345 |
| 34 | ZAK | 1.23581028 |
| 35 | NME2 | 1.23507062 |
| 36 | RIPK4 | 1.23316011 |
| 37 | CDC7 | 1.20935997 |
| 38 | IKBKE | 1.20546189 |
| 39 | SIK3 | 1.14292377 |
| 40 | BTK | 1.13026711 |
| 41 | IRAK4 | 1.12548160 |
| 42 | SIK2 | 1.11024426 |
| 43 | VRK1 | 1.06072403 |
| 44 | NLK | 1.04443677 |
| 45 | TYRO3 | 1.03969997 |
| 46 | MAP3K14 | 0.97205494 |
| 47 | MELK | 0.95071048 |
| 48 | TESK1 | 0.92915513 |
| 49 | HCK | 0.91887360 |
| 50 | TTN | 0.88827137 |
| 51 | DMPK | 0.88747604 |
| 52 | ADRBK2 | 0.88507496 |
| 53 | TBK1 | 0.86376169 |
| 54 | PASK | 0.85242762 |
| 55 | GRK1 | 0.76835932 |
| 56 | TAOK2 | 0.73256290 |
| 57 | MAP3K10 | 0.72953142 |
| 58 | STK24 | 0.71619828 |
| 59 | ILK | 0.70576876 |
| 60 | ALK | 0.68501838 |
| 61 | TRPM7 | 0.68014410 |
| 62 | FGFR3 | 0.67694316 |
| 63 | PINK1 | 0.66865929 |
| 64 | LYN | 0.66436007 |
| 65 | PRKD3 | 0.61088321 |
| 66 | TSSK6 | 0.60883484 |
| 67 | FYN | 0.59630067 |
| 68 | ROCK1 | 0.59539713 |
| 69 | TRIB3 | 0.59381399 |
| 70 | IGF1R | 0.58769376 |
| 71 | MAP2K6 | 0.57389536 |
| 72 | ADRBK1 | 0.55637746 |
| 73 | PIK3CG | 0.54473472 |
| 74 | INSR | 0.53384423 |
| 75 | KIT | 0.51471203 |
| 76 | TLK1 | 0.50725164 |
| 77 | JAK2 | 0.50203436 |
| 78 | MAP3K3 | 0.49384908 |
| 79 | MARK3 | 0.47557681 |
| 80 | CSF1R | 0.46386093 |
| 81 | DAPK1 | 0.45680646 |
| 82 | TAOK1 | 0.45390018 |
| 83 | NUAK1 | 0.43927674 |
| 84 | MAP3K5 | 0.42768922 |
| 85 | EIF2AK1 | 0.40966447 |
| 86 | PRKCD | 0.40328426 |
| 87 | PIM1 | 0.40094361 |
| 88 | BUB1 | 0.39915772 |
| 89 | NEK2 | 0.39645604 |
| 90 | FRK | 0.36735957 |
| 91 | BCKDK | 0.36679804 |
| 92 | GRK5 | 0.35883993 |
| 93 | WNK4 | 0.34713527 |
| 94 | ERBB3 | 0.34327137 |
| 95 | CDK19 | 0.33069833 |
| 96 | CDK18 | 0.33040053 |
| 97 | MAP4K2 | 0.32509354 |
| 98 | TGFBR2 | 0.31520500 |
| 99 | PDK1 | 0.31394669 |
| 100 | PDGFRB | 0.31334214 |
| 101 | MAP3K13 | 0.29259173 |
| 102 | RPS6KL1 | 0.28730160 |
| 103 | RPS6KC1 | 0.28730160 |
| 104 | CDK4 | 0.28587720 |
| 105 | CDK15 | 0.28431493 |
| 106 | PRKG2 | 0.28127752 |
| 107 | OBSCN | 0.27777210 |
| 108 | RPS6KA5 | 0.27674594 |
| 109 | STK38 | 0.26586920 |
| 110 | RAF1 | 0.26519166 |
| 111 | CDK11A | 0.26467210 |
| 112 | RPS6KA6 | 0.25413850 |
| 113 | TAOK3 | 0.25175867 |
| 114 | MAPK11 | 0.25073755 |
| 115 | PRKCA | 0.24890059 |
| 116 | ROCK2 | 0.24410339 |
| 117 | EEF2K | 0.24394329 |
| 118 | EPHB1 | 0.24375228 |
| 119 | PRPF4B | 0.24339310 |
| 120 | PRKCB | 0.23252151 |
| 121 | INSRR | 0.23161120 |
| 122 | IKBKB | 0.23128437 |
| 123 | PAK1 | 0.22695209 |
| 124 | NEK9 | 0.22351282 |
| 125 | CSNK1G3 | 0.22014134 |
| 126 | BMPR2 | 0.21970895 |
| 127 | MYLK | 0.21511325 |
| 128 | LIMK1 | 0.21145062 |
| 129 | ERBB2 | 0.20852264 |
| 130 | FGR | 0.20763463 |
| 131 | MAPKAPK2 | 0.20257474 |
| 132 | RPS6KA4 | 0.19402526 |
| 133 | EGFR | 0.18987654 |
| 134 | BMX | 0.18971665 |
| 135 | AURKB | 0.16463325 |
| 136 | ABL1 | 0.16345006 |
| 137 | SRC | 0.16219649 |
| 138 | MAPK9 | 0.14807773 |
| 139 | NEK6 | 0.14390108 |
| 140 | PRKACA | 0.13331777 |
| 141 | MAPK15 | 0.12720713 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 8.40901219 |
| 2 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 4.96036135 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.65591210 |
| 4 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.91107132 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.49180107 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 3.37652120 |
| 7 | Viral myocarditis_Homo sapiens_hsa05416 | 2.72984021 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.54287041 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.44601908 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.41320918 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.19376278 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.12571689 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.01045079 |
| 14 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.76632607 |
| 15 | Ribosome_Homo sapiens_hsa03010 | 1.48975830 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.39892204 |
| 17 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.39186165 |
| 18 | Phototransduction_Homo sapiens_hsa04744 | 1.38077389 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.31027803 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.18732595 |
| 21 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.15598776 |
| 22 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.14904836 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.14106226 |
| 24 | DNA replication_Homo sapiens_hsa03030 | 1.13425896 |
| 25 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.11156295 |
| 26 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.10293358 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.08955348 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.03179872 |
| 29 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.01781233 |
| 30 | Mismatch repair_Homo sapiens_hsa03430 | 1.01283211 |
| 31 | Shigellosis_Homo sapiens_hsa05131 | 1.00888346 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.99230516 |
| 33 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.98707934 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.97360144 |
| 35 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.94772272 |
| 36 | Proteasome_Homo sapiens_hsa03050 | 0.93162194 |
| 37 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.89468017 |
| 38 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.87177905 |
| 39 | Base excision repair_Homo sapiens_hsa03410 | 0.81696799 |
| 40 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.79930426 |
| 41 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.77448541 |
| 42 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77384902 |
| 43 | Platelet activation_Homo sapiens_hsa04611 | 0.76723439 |
| 44 | Legionellosis_Homo sapiens_hsa05134 | 0.76499851 |
| 45 | Huntingtons disease_Homo sapiens_hsa05016 | 0.73638001 |
| 46 | Asthma_Homo sapiens_hsa05310 | 0.72620026 |
| 47 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71146401 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 0.70629108 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.69398211 |
| 50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.69076840 |
| 51 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.69015577 |
| 52 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68430208 |
| 53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.67265331 |
| 54 | Salmonella infection_Homo sapiens_hsa05132 | 0.63695738 |
| 55 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.63549528 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62027872 |
| 57 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.61872897 |
| 58 | Hepatitis B_Homo sapiens_hsa05161 | 0.61830636 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.60900726 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 0.60316561 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58601772 |
| 62 | Pertussis_Homo sapiens_hsa05133 | 0.58234411 |
| 63 | Malaria_Homo sapiens_hsa05144 | 0.57098424 |
| 64 | Influenza A_Homo sapiens_hsa05164 | 0.56269260 |
| 65 | RNA polymerase_Homo sapiens_hsa03020 | 0.55137248 |
| 66 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53345423 |
| 67 | Peroxisome_Homo sapiens_hsa04146 | 0.52398010 |
| 68 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.50563889 |
| 69 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.50091534 |
| 70 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.49375903 |
| 71 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.49133612 |
| 72 | Colorectal cancer_Homo sapiens_hsa05210 | 0.47379636 |
| 73 | Tuberculosis_Homo sapiens_hsa05152 | 0.45431341 |
| 74 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.43415897 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.41037291 |
| 76 | Taste transduction_Homo sapiens_hsa04742 | 0.40807153 |
| 77 | Retinol metabolism_Homo sapiens_hsa00830 | 0.39272967 |
| 78 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38447096 |
| 79 | Long-term potentiation_Homo sapiens_hsa04720 | 0.37167579 |
| 80 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.36421856 |
| 81 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.35841895 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35403815 |
| 83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.34699799 |
| 84 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.34142479 |
| 85 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33899459 |
| 86 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.33677139 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.33138713 |
| 88 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.29244967 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.28585202 |
| 90 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.28584222 |
| 91 | Phagosome_Homo sapiens_hsa04145 | 0.28523371 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.28496405 |
| 93 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.27521680 |
| 94 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.27439595 |
| 95 | Renin secretion_Homo sapiens_hsa04924 | 0.27388292 |
| 96 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.27053699 |
| 97 | Parkinsons disease_Homo sapiens_hsa05012 | 0.26819621 |
| 98 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.25355909 |
| 99 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.24411583 |
| 100 | Spliceosome_Homo sapiens_hsa03040 | 0.23019497 |
| 101 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.22930983 |
| 102 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.22193714 |
| 103 | RNA degradation_Homo sapiens_hsa03018 | 0.19838880 |
| 104 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.19121626 |
| 105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.18876382 |
| 106 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.18411787 |
| 107 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.17690648 |
| 108 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.17428555 |
| 109 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.17102330 |
| 110 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.16810471 |
| 111 | Prion diseases_Homo sapiens_hsa05020 | 0.16779144 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.16371732 |
| 113 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.15814284 |
| 114 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.15646538 |
| 115 | Nicotine addiction_Homo sapiens_hsa05033 | 0.14097925 |
| 116 | Purine metabolism_Homo sapiens_hsa00230 | 0.13978028 |
| 117 | Morphine addiction_Homo sapiens_hsa05032 | 0.13958285 |
| 118 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.13433642 |
| 119 | Salivary secretion_Homo sapiens_hsa04970 | 0.12443711 |
| 120 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.12328089 |
| 121 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.11809167 |
| 122 | Focal adhesion_Homo sapiens_hsa04510 | 0.11507384 |
| 123 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.10401683 |
| 124 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.09992518 |
| 125 | Cell cycle_Homo sapiens_hsa04110 | 0.09885067 |
| 126 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.08576636 |
| 127 | Protein export_Homo sapiens_hsa03060 | 0.08031343 |
| 128 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.07882416 |
| 129 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.07535615 |
| 130 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.07522780 |
| 131 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.06296079 |
| 132 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.05744633 |
| 133 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.05712956 |
| 134 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.04830679 |
| 135 | Alzheimers disease_Homo sapiens_hsa05010 | 0.04427682 |
| 136 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.03203469 |
| 137 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.02849246 |
| 138 | Olfactory transduction_Homo sapiens_hsa04740 | 0.02693728 |
| 139 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.02059664 |

